title: Relapse pattern of GOG 122 trial should be more informative.
authors.forename: Enis
authors.initials: E
authors.lastname: Ozyar
authors.forename: Mine
authors.initials: M
authors.lastname: Genc
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D017024:Chemotherapy, Adjuvant; D017326:Clinical Trials, Phase III as Topic; D018572:Disease-Free Survival; D016889:Endometrial Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000532:radiotherapy*; D005260:Female; D006801:Humans; D015337:Multicenter Studies as Topic; D018714:Radiotherapy, Adjuvant; D016032:Randomized Controlled Trials as Topic; D016019:Survival Analysis; D017211:Treatment Failure; D016896:Treatment Outcome